Side-by-side comparison of AI visibility scores, market position, and capabilities
Turns smartphones into clinical-grade diagnostic devices; FDA-cleared for at-home urinalysis (kidney disease), wound care, and UTI testing; $218M raised including $50M Series D in 2023.
Healthy.io is a digital health company that transforms standard smartphones into clinical-grade medical diagnostic tools using computer vision and colorimetric image analysis. Founded in 2013 and headquartered in Tel Aviv, Israel (with U.S. operations), Healthy.io's core technology enables patients to conduct laboratory-quality tests at home using a companion test strip and the smartphone camera, without any additional hardware. The company's Minuteful Kidney product is FDA-cleared for at-home urine albumin-to-creatinine ratio (ACR) testing — a critical marker for chronic kidney disease — and is used by major U.S. health systems and insurers to enable remote monitoring at scale. Healthy.io also offers at-home wound care monitoring and UTI testing using the same smartphone-based platform.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.